N-[2-[3-[4-[5-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-[4-(trifluoromethyl)phenyl]imidazol-1-yl]piperidin-1-yl]propyl-methylamino]ethyl]-2-[4-[5-[6-(3,5-dimethylphenoxy)-2-pyridinyl]-4-methyltriazol-1-yl]piperidin-1-yl]acetamide
C56H66F3N13O2 — CID 166119763
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[3-[4-[5-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-[4-(trifluoromethyl)phenyl]imidazol-1-yl]piperidin-1-yl]propyl-methylamino]ethyl]-2-[4-[5-[6-(3,5-dimethylphenoxy)-2-pyridinyl]-4-methyltriazol-1-yl]piperidin-1-yl]acetamide
N-[2-[3-[4-[5-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-[4-(trifluoromethyl)phenyl]imidazol-1-yl]piperidin-1-yl]propyl-methylamino]ethyl]-2-[4-[5-[6-(3,5-dimethylphenoxy)-2-pyridinyl]-4-methyltriazol-1-yl]piperidin-1-yl]acetamide (PubChem CID 166119763) has the molecular formula C56H66F3N13O2 and a molecular weight of 1010.23 g/mol. Its IUPAC name is N-[2-[3-[4-[5-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-[4-(trifluoromethyl)phenyl]imidazol-1-yl]piperidin-1-yl]propyl-methylamino]ethyl]-2-[4-[5-[6-(3,5-dimethylphenoxy)-2-pyridinyl]-4-methyltriazol-1-yl]piperidin-1-yl]acetamide.
Molecular Properties
| Compound Name | N-[2-[3-[4-[5-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-[4-(trifluoromethyl)phenyl]imidazol-1-yl]piperidin-1-yl]propyl-methylamino]ethyl]-2-[4-[5-[6-(3,5-dimethylphenoxy)-2-pyridinyl]-4-methyltriazol-1-yl]piperidin-1-yl]acetamide |
|---|---|
| PubChem CID | 166119763 |
| Molecular Formula | C56H66F3N13O2 |
| Molecular Weight | 1010.23 g/mol |
| Exact Mass | 1009.54 |
| IUPAC Name | N-[2-[3-[4-[5-[2-(3,5-dimethylanilino)pyrimidin-4-yl]-4-[4-(trifluoromethyl)phenyl]imidazol-1-yl]piperidin-1-yl]propyl-methylamino]ethyl]-2-[4-[5-[6-(3,5-dimethylphenoxy)-2-pyridinyl]-4-methyltriazol-1-yl]piperidin-1-yl]acetamide |
| SMILES | Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)ncn3C3CCN(CCCN(C)CCNC(=O)CN4CCC(n5nnc(C)c5-c5cccc(Oc6cc(C)cc(C)c6)n5)CC4)CC3)n2)c1 |
| InChI | InChI=1S/C56H66F3N13O2/c1-37-29-38(2)32-44(31-37)63-55-61-20-15-49(65-55)54-52(42-11-13-43(14-12-42)56(57,58)59)62-36-71(54)45-16-24-69(25-17-45)23-8-22-68(6)28-21-60-50(73)35-70-26-18-46(19-27-70)72-53(41(5)66-67-72)48-9-7-10-51(64-48)74-47-33-39(3)30-40(4)34-47/h7,9-15,20,29-34,36,45-46H,8,16-19,21-28,35H2,1-6H3,(H,60,73)(H,61,63,65) |
| InChIKey | RAAHMQLRJVWCTG-UHFFFAOYSA-N |
| XLogP | 10.17 |
| TPSA | 147.28 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 74 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1010.23 |
| LogP ≤ 5 | 10.17 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166119763 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.